Cargando…
P1301: BIOLOGICAL SIGNIFICANCE OF UCK2 IN HTLV-1-INFECTED CELLS IN ATL LEUKEMOGENESIS AND ACQUIRED RESISTANCE TO AZACITIDINE
Autores principales: | Watanabe, T., Yamamoto, Y., Kamachi, K., Kurahashi, Y., Yoshida-Sakai, N., Ureshino, H., Fukuda-Kurahashi, Y., Nakamura, H., Sueoka, E., Kimura, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429587/ http://dx.doi.org/10.1097/01.HS9.0000848068.85910.33 |
Ejemplares similares
-
P1236: REGULATION OF DNA AND HISTONE METHYLATION THROUGH METHIONINE METABOLISM IN ATL LEUKEMOGENESIS
por: Watanabe, Tatsuro, et al.
Publicado: (2023) -
Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL
por: Kurahashi, Yuki, et al.
Publicado: (2022) -
Adult T‐cell leukemia‐lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism
por: Yoshida‐Sakai, Nao, et al.
Publicado: (2021) -
Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia
por: Kamachi, Kazuharu, et al.
Publicado: (2023) -
A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation
por: Kawasoe, Kazunori, et al.
Publicado: (2023)